The latest product in febit’s Geniom family, the Geniom RT Analyzer enables the fully-automated processing of microarrays on the company’s Geniom biochips. The compact all-in-one device, which employs microfluidics, provides users with high sample throughput, excellent reproducibility, high sensitivity, and a variety of applications. In addition, the product’s freely-programmable and precise temperature control optimizes hybridizations and enables the use of enzymatic reactions directly on the microfluidic array for signal enhancement and primer extension assays.
febit offers microarray analytics for a broad spectrum of DNA and RNA samples. The array design can be chosen from current databases or freely configured by the user. Geniom arrays are produced on demand at febit and subject to rigorous quality control before shipment to the customer. Alternatively, researchers may prefer the Geniom One System, which enables integrated microarray synthesis in the user´s own laboratory. This provides an independent workflow with complete control of the microarray experiments. Both instruments can be utilized in combination.
This article was published in Drug Discovery & Development magazine: Vol. 11, No. 7, July, 2008, pp. 23.
Filed Under: Genomics/Proteomics
![A display of DNA sequencing output from an automated ABI 373 sequencer. [National Human Genome Research Institute (NHGRI)]](https://www.drugdiscoverytrends.com/wp-content/uploads/2024/06/51187236177_b7b566a401_k-268x170.jpg)
